| Year |
Citation |
Score |
| 2024 |
Yamazaki T, Kouno T, Hsu CL, Hartmann P, Mayo S, Zhang X, Stärkel P, Bosques-Padilla F, Verna EC, Abraldes JG, Brown RS, Vargas V, Altamirano J, Caballería J, Shawcross DL, ... ... Schnabl B, et al. Serum aryl hydrocarbon receptor activity is associated with survival in patients with alcohol-associated hepatitis. Hepatology (Baltimore, Md.). PMID 38377466 DOI: 10.1097/HEP.0000000000000777 |
0.304 |
|
| 2024 |
Schöler D, Schnabl B. The role of the microbiome in liver disease. Current Opinion in Gastroenterology. PMID 38362864 DOI: 10.1097/MOG.0000000000001013 |
0.484 |
|
| 2024 |
Viebahn G, Hartmann P, Lang S, Demir M, Zhang X, Fouts DE, Stärkel P, Schnabl B. Fungal signature differentiates alcohol-associated liver disease from nonalcoholic fatty liver disease. Gut Microbes. 16: 2307586. PMID 38298161 DOI: 10.1080/19490976.2024.2307586 |
0.427 |
|
| 2023 |
Özdirik B, Schnabl B. Microbial Players in Primary Sclerosing Cholangitis: Current Evidence and Concepts. Cellular and Molecular Gastroenterology and Hepatology. PMID 38109970 DOI: 10.1016/j.jcmgh.2023.12.005 |
0.448 |
|
| 2023 |
Cabré N, Yang Y, Wang Y, Schnabl B. Development of a Quantitative PCR Method for Detecting Cytolysin in Human Stool Samples. Methods and Protocols. 6. PMID 37987354 DOI: 10.3390/mps6060107 |
0.35 |
|
| 2023 |
Fujiki J, Schnabl B. Phage therapy: Targeting intestinal bacterial microbiota for the treatment of liver diseases. Jhep Reports : Innovation in Hepatology. 5: 100909. PMID 37965159 DOI: 10.1016/j.jhepr.2023.100909 |
0.364 |
|
| 2023 |
Ranjbarian T, Schnabl B. Gut-microbiome centered therapies for alcohol-associated liver disease. Seminars in Liver Disease. PMID 37527781 DOI: 10.1055/a-2145-7331 |
0.519 |
|
| 2023 |
Cheng Z, Chen Y, Schnabl B, Chu H, Yang L. Bile acid and nonalcoholic steatohepatitis: Molecular insights and therapeutic targets. Journal of Advanced Research. PMID 37356804 DOI: 10.1016/j.jare.2023.06.009 |
0.315 |
|
| 2023 |
Hsu CL, Schnabl B. The gut-liver axis and gut microbiota in health and liver disease. Nature Reviews. Microbiology. PMID 37316582 DOI: 10.1038/s41579-023-00904-3 |
0.479 |
|
| 2023 |
Hartmann P, Lang S, Schierwagen R, Klein S, Praktiknjo M, Trebicka J, Schnabl B. Fecal cytolysin does not predict disease severity in acutely decompensated cirrhosis and acute-on-chronic liver failure. Hepatobiliary & Pancreatic Diseases International : Hbpd Int. PMID 37198098 DOI: 10.1016/j.hbpd.2023.05.003 |
0.327 |
|
| 2023 |
Yamazaki T, Schnabl B. Acute alcohol-associated hepatitis: Latest findings in non-invasive biomarkers and treatment. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 37183549 DOI: 10.1111/liv.15608 |
0.35 |
|
| 2023 |
Maccioni L, Kasavuli J, Leclercq S, Pirlot B, Laloux G, Horsmans Y, Leclercq I, Schnabl B, Stärkel P. Toll-like receptor 2 activation in monocytes contributes to systemic inflammation and alcohol-associated liver disease in humans. Hepatology Communications. 7. PMID 37058088 DOI: 10.1097/HC9.0000000000000107 |
0.46 |
|
| 2023 |
Hartmann P, Zhang X, Loomba R, Schnabl B. Global and national prevalence of nonalcoholic fatty liver disease in adolescents: an analysis of the global burden of disease study 2019. Hepatology (Baltimore, Md.). PMID 37021791 DOI: 10.1097/HEP.0000000000000383 |
0.307 |
|
| 2023 |
Zeng S, Rosati E, Saggau C, Messner B, Chu H, Duan Y, Hartmann P, Wang Y, Ma S, Huang WJM, Lee J, Lee SM, Carvalho-Gontijo R, Zhang V, Hoffmann JP, ... ... Schnabl B, et al. Candida albicans-specific Th17 cell-mediated response contributes to alcohol-associated liver disease. Cell Host & Microbe. 31: 389-404.e7. PMID 36893735 DOI: 10.1016/j.chom.2023.02.001 |
0.609 |
|
| 2023 |
Kouno T, Zeng S, Wang Y, Duan Y, Lang S, Gao B, Hartmann P, Cabré N, Llorente C, Galbert C, Emond P, Sokol H, James M, Chao CC, Gao JR, ... ... Schnabl B, et al. Engineered bacteria producing aryl-hydrocarbon receptor agonists protect against ethanol-induced liver disease in mice. Alcoholism, Clinical and Experimental Research. PMID 36871955 DOI: 10.1111/acer.15048 |
0.386 |
|
| 2023 |
Cabré N, Hartmann P, Llorente C, Kouno T, Wang Y, Zeng S, Kim HY, Zhang X, Kisseleva T, Iyer S, Kudumala S, Schnabl B. Immunoglobulin Y antibodies against cytolysin reduce ethanol-induced liver disease in mice. Hepatology (Baltimore, Md.). PMID 36811393 DOI: 10.1097/HEP.0000000000000324 |
0.414 |
|
| 2023 |
Hsu CL, Wang Y, Duan Y, Chu H, Hartmann P, Llorente C, Zhou R, Schnabl B. Differences in Bacterial Translocation and Liver Injury in Ethanol Versus Diet-Induced Liver Disease. Digestive Diseases and Sciences. PMID 36807831 DOI: 10.1007/s10620-023-07860-1 |
0.534 |
|
| 2023 |
Zeng S, Hartmann P, Park M, Duan Y, Lang S, Llorente C, Wang Y, Cabré N, Fouts DE, Bacher P, Jung WH, Stärkel P, Schnabl B. Malassezia restricta promotes alcohol-induced liver injury. Hepatology Communications. 7: e0029. PMID 36706195 DOI: 10.1097/HC9.0000000000000029 |
0.443 |
|
| 2023 |
Hendrikx T, Lang S, Rajcic D, Wang Y, McArdle S, Kim K, Mikulski Z, Schnabl B. Hepatic pIgR-mediated secretion of IgA limits bacterial translocation and prevents ethanol-induced liver disease in mice. Gut. PMID 36690432 DOI: 10.1136/gutjnl-2022-328265 |
0.489 |
|
| 2023 |
Hsu CL, Lang S, Demir M, Fouts DE, Stärkel P, Schnabl B. Any alcohol use in NAFLD patients is associated with significant changes to the intestinal virome. Hepatology (Baltimore, Md.). PMID 36631002 DOI: 10.1097/HEP.0000000000000238 |
0.355 |
|
| 2022 |
Hartmann P, Schnabl B. Fungal infections and the fungal microbiome in hepatobiliary disorders. Journal of Hepatology. PMID 36565724 DOI: 10.1016/j.jhep.2022.12.006 |
0.333 |
|
| 2022 |
Gao B, Zhu Y, Shen W, Stärkel P, Schnabl B. Correlation between Serum Steroid Hormones and Gut Microbiota in Patients with Alcohol-Associated Liver Disease. Metabolites. 12. PMID 36422247 DOI: 10.3390/metabo12111107 |
0.386 |
|
| 2022 |
Philips CA, Schnabl B, Bajaj JS. Gut Microbiome and Alcohol-associated Liver Disease. Journal of Clinical and Experimental Hepatology. 12: 1349-1359. PMID 36157139 DOI: 10.1016/j.jceh.2021.12.016 |
0.501 |
|
| 2022 |
Carvalho-Gontijo R, Han C, Zhang L, Zhang V, Hosseini M, Mekeel K, Schnabl B, Loomba R, Karin M, Brenner DA, Kisseleva T. Metabolic Injury of Hepatocytes Promotes Progression of NAFLD and AALD. Seminars in Liver Disease. 42: 233-249. PMID 36001995 DOI: 10.1055/s-0042-1755316 |
0.634 |
|
| 2022 |
Martino C, Zaramela LS, Gao B, Embree M, Tarasova J, Parker SJ, Wang Y, Chu H, Chen P, Lee KC, Galzerani DD, Gengatharan JM, Lekbua A, Neal M, Knight R, ... ... Schnabl B, et al. Acetate reprograms gut microbiota during alcohol consumption. Nature Communications. 13: 4630. PMID 35941112 DOI: 10.1038/s41467-022-31973-2 |
0.349 |
|
| 2022 |
Maccioni L, Loriot A, Dewulf J, Bommer G, Horsmans Y, Lanthier N, Leclercq I, Schnabl B, Stärkel P. Duodenal CD8+ T resident memory cell apoptosis contributes to gut barrier dysfunction and microbial translocation in early alcohol-associated liver disease in humans. Alimentary Pharmacology & Therapeutics. PMID 35919965 DOI: 10.1111/apt.17177 |
0.413 |
|
| 2022 |
Hasa E, Hartmann P, Schnabl B. Liver cirrhosis and immune dysfunction. International Immunology. PMID 35792761 DOI: 10.1093/intimm/dxac030 |
0.407 |
|
| 2022 |
Gao B, Zeng S, Maccioni L, Shi X, Armando A, Quehenberger O, Zhang X, Stärkel P, Schnabl B. Lipidomics for the Prediction of Progressive Liver Disease in Patients with Alcohol Use Disorder. Metabolites. 12. PMID 35629937 DOI: 10.3390/metabo12050433 |
0.456 |
|
| 2022 |
Kouno T, Liu X, Zhao H, Kisseleva T, Cable EE, Schnabl B. Selective PPARδ agonist seladelpar suppresses bile acid synthesis by reducing hepatocyte CYP7A1 via the fibroblast growth factor 21 signaling pathway. The Journal of Biological Chemistry. 298: 102056. PMID 35605662 DOI: 10.1016/j.jbc.2022.102056 |
0.324 |
|
| 2022 |
Bajaj JS, Ng SC, Schnabl B. Promises of microbiome-based therapies. Journal of Hepatology. 76: 1379-1391. PMID 35589257 DOI: 10.1016/j.jhep.2021.12.003 |
0.416 |
|
| 2022 |
Hsu CL, Zhang X, Jiang L, Lang S, Hartmann P, Pride D, Fouts DE, Stärkel P, Schnabl B. Intestinal virome in patients with alcohol use disorder and after abstinence. Hepatology Communications. PMID 35368152 DOI: 10.1002/hep4.1947 |
0.436 |
|
| 2022 |
Mendes BG, Duan Y, Schnabl B. Immune Response of an Oral Phage Cocktail in a Mouse Model of Ethanol-Induced Liver Disease. Viruses. 14. PMID 35336897 DOI: 10.3390/v14030490 |
0.38 |
|
| 2022 |
Jiménez C, Ventura-Cots M, Sala M, Calafat M, Garcia-Retortillo M, Cirera I, Cañete N, Soriano G, Poca M, Simón-Talero M, Altamirano J, Lucey M, Garcia-Tsao G, Brown RS, Schwabe RF, ... ... Schnabl B, et al. Effect of rifaximin on infections, acute-on-chronic liver failure and mortality in alcoholic hepatitis: a pilot study (RIFA-AH). Liver International : Official Journal of the International Association For the Study of the Liver. PMID 35220659 DOI: 10.1111/liv.15207 |
0.326 |
|
| 2022 |
Czernuszewicz TJ, Aji AM, Moore CJ, Montgomery SA, Velasco B, Torres G, Anand KS, Johnson KA, Deal AM, Zukić D, McCormick M, Schnabl B, Gallippi CM, Dayton PA, Gessner RC. Development of a Robotic Shear Wave Elastography System for Noninvasive Staging of Liver Disease in Murine Models. Hepatology Communications. PMID 35202510 DOI: 10.1002/hep4.1912 |
0.373 |
|
| 2022 |
Hartmann P, Duan Y, Miyamoto Y, Demir M, Lang S, Hasa E, Stern P, Yamashita D, Conrad M, Eckmann L, Schnabl B. Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice. Hepatology International. PMID 35075592 DOI: 10.1007/s12072-022-10296-w |
0.335 |
|
| 2022 |
Gao B, Wu TC, Lang S, Jiang L, Duan Y, Fouts DE, Zhang X, Tu XM, Schnabl B. Machine Learning Applied to Omics Datasets Predicts Mortality in Patients with Alcoholic Hepatitis. Metabolites. 12. PMID 35050163 DOI: 10.3390/metabo12010041 |
0.318 |
|
| 2022 |
Schnabl B, Arteel GE, Stickel F, Hengstler J, Vartak N, Ghallab A, Dooley S, Li Y, Schwabe RF. Liver specific, systemic and genetic contributors to alcohol-related liver disease progression. Zeitschrift Fur Gastroenterologie. 60: 36-44. PMID 35042252 DOI: 10.1055/a-1714-9330 |
0.521 |
|
| 2022 |
Zeng S, Schnabl B. Roles for the mycobiome in liver disease. Liver International : Official Journal of the International Association For the Study of the Liver. 42: 729-741. PMID 34995410 DOI: 10.1111/liv.15160 |
0.439 |
|
| 2021 |
Demir M, Lang S, Hartmann P, Duan Y, Martin A, Miyamoto Y, Bondareva M, Zhang X, Wang Y, Kasper P, Bang C, Roderburg C, Tacke F, Steffen HM, Goeser T, ... ... Schnabl B, et al. The fecal mycobiome in non-alcoholic fatty liver disease. Journal of Hepatology. PMID 34896404 DOI: 10.1016/j.jhep.2021.11.029 |
0.521 |
|
| 2021 |
Duan Y, Chu H, Brandl K, Jiang L, Zeng S, Meshgin N, Papachristoforou E, Argemi J, Mendes BG, Wang Y, Su H, Sun W, Llorente C, Hendrikx T, Liu X, ... ... Schnabl B, et al. CRIg on liver macrophages clears pathobionts and protects against alcoholic liver disease. Nature Communications. 12: 7172. PMID 34887405 DOI: 10.1038/s41467-021-27385-3 |
0.644 |
|
| 2021 |
Maccioni L, Leclercq IA, Schnabl B, Stärkel P. Host Factors in Dysregulation of the Gut Barrier Function during Alcohol-Associated Liver Disease. International Journal of Molecular Sciences. 22. PMID 34884492 DOI: 10.3390/ijms222312687 |
0.502 |
|
| 2021 |
Gao B, Zhu Y, Gao N, Shen W, Stärkel P, Schnabl B. Integrative Analysis of Metabolome and Microbiome in Patients with Progressive Alcohol-Associated Liver Disease. Metabolites. 11. PMID 34822424 DOI: 10.3390/metabo11110766 |
0.455 |
|
| 2021 |
Jiang L, Wang Y, Xiao Y, Wang Y, Yan J, Schnabl B, Cai W. Role of the Gut Microbiota in Parenteral Nutrition-associated Liver Disease: From Current Knowledge to Future Opportunities. The Journal of Nutrition. PMID 34734271 DOI: 10.1093/jn/nxab380 |
0.334 |
|
| 2021 |
Schnabl B. Update on the Role of the Gut Microbiota on Alcohol-Associated Liver Disease. Gastroenterology & Hepatology. 17: 381-383. PMID 34602901 |
0.48 |
|
| 2021 |
Qian M, Liu J, Zhao D, Cai P, Pan C, Jia W, Gao Y, Zhang Y, Zhang N, Zhang Y, Zhang Q, Wu D, Shan C, Zhang M, Schnabl B, et al. Aryl hydrocarbon receptor deficiency in intestinal epithelial cells aggravates alcohol-related liver disease. Cellular and Molecular Gastroenterology and Hepatology. PMID 34454169 DOI: 10.1016/j.jcmgh.2021.08.014 |
0.456 |
|
| 2021 |
Hsu C, Duan Y, Fouts DE, Schnabl B. Intestinal virome and therapeutic potential of bacteriophages in liver disease. Journal of Hepatology. PMID 34437908 DOI: 10.1016/j.jhep.2021.08.003 |
0.455 |
|
| 2021 |
Hartmann P, Lang S, Zeng S, Duan Y, Zhang X, Wang Y, Bondareva M, Kruglov A, Fouts DE, Stärkel P, Schnabl B. Dynamic Changes of the Fungal Microbiome in Alcohol Use Disorder. Frontiers in Physiology. 12: 699253. PMID 34349667 DOI: 10.3389/fphys.2021.699253 |
0.378 |
|
| 2021 |
Cabré N, Duan Y, Llorente C, Conrad M, Stern P, Yamashita D, Schnabl B. Colesevelam Reduces Ethanol-Induced Liver Steatosis in Humanized Gnotobiotic Mice. Cells. 10. PMID 34198609 DOI: 10.3390/cells10061496 |
0.467 |
|
| 2021 |
Musto JA, Eickhoff J, Ventura-Cots M, Abraldes JG, Bosques-Padilla F, Verna EC, Brown RS, Vargas V, Altamirano J, Caballería J, Shawcross D, Louvet A, Mathurin P, Garcia-Tsao G, Schnabl B, et al. The level of alcohol consumption in the prior year does not impact clinical outcomes in patients with alcohol-associated hepatitis (AH). Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. PMID 34109723 DOI: 10.1002/lt.26203 |
0.336 |
|
| 2021 |
Ganguly S, Muench GA, Shang L, Rosenthal SB, Rahman G, Wang R, Wang Y, Kwon HC, Diomino AM, Kisseleva T, Soorosh P, Hosseini M, Knight R, Schnabl B, Brenner DA, et al. Non-alcoholic Steatohepatitis and HCC in a Hyperphagic Mouse Accelerated by Western Diet. Cellular and Molecular Gastroenterology and Hepatology. PMID 34062281 DOI: 10.1016/j.jcmgh.2021.05.010 |
0.543 |
|
| 2021 |
Trebicka J, Macnaughtan J, Schnabl B, Shawcross DL, Bajaj JS. The microbiota in cirrhosis and its role in hepatic decompensation. Journal of Hepatology. S67-S81. PMID 34039493 DOI: 10.1016/j.jhep.2020.11.013 |
0.341 |
|
| 2021 |
Hartmann P, Schnabl B. New Developments in Microbiome in Alcohol-Associated and Nonalcoholic Fatty Liver Disease. Seminars in Liver Disease. 41: 87-102. PMID 33957682 DOI: 10.1055/s-0040-1719174 |
0.482 |
|
| 2021 |
Lang S, Martin A, Zhang X, Farowski F, Wisplinghoff H, Vehreschild MJGT, Krawczyk M, Nowag A, Kretzschmar A, Scholz C, Kasper P, Roderburg C, Mohr R, Lammert F, Tacke F, ... Schnabl B, et al. Combined analysis of gut microbiota, diet and PNPLA3 polymorphism in biopsy-proven non-alcoholic fatty liver disease. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 33896117 DOI: 10.1111/liv.14899 |
0.405 |
|
| 2021 |
Gao B, Zhang X, Schnabl B. Fungi-Bacteria Correlation in Alcoholic Hepatitis Patients. Toxins. 13. PMID 33672887 DOI: 10.3390/toxins13020143 |
0.467 |
|
| 2021 |
Gao B, Argemi J, Bataller R, Schnabl B. Serum Acylcarnitines Associated with High Short-Term Mortality in Patients with Alcoholic Hepatitis. Biomolecules. 11. PMID 33672832 DOI: 10.3390/biom11020281 |
0.433 |
|
| 2021 |
Zhou R, Llorente C, Cao J, Zaramela LS, Zeng S, Gao B, Li SZ, Welch RD, Huang FQ, Qi LW, Pan C, Huang Y, Zhou P, Beussen I, Zhang Y, ... ... Schnabl B, et al. Intestinal α1-2-fucosylation contributes to obesity and steatohepatitis in mice. Cellular and Molecular Gastroenterology and Hepatology. PMID 33631374 DOI: 10.1016/j.jcmgh.2021.02.009 |
0.419 |
|
| 2021 |
Fairfield B, Schnabl B. Gut dysbiosis as a driver in alcohol-induced liver injury. Jhep Reports : Innovation in Hepatology. 3: 100220. PMID 33598648 DOI: 10.1016/j.jhepr.2020.100220 |
0.461 |
|
| 2020 |
Zhang Q, Ma C, Duan Y, Heinrich B, Rosato U, Diggs LP, Ma L, Roy S, Fu Q, Brown ZJ, Wabitsch S, Thovarai V, Fu J, Feng D, Ruf B, ... ... Schnabl B, et al. Gut microbiome directs hepatocytes to recruit MDSC and promote cholangiocarcinoma. Cancer Discovery. PMID 33323397 DOI: 10.1158/2159-8290.CD-20-0304 |
0.392 |
|
| 2020 |
Wang R, Tang R, Li B, Ma X, Schnabl B, Tilg H. Gut microbiome, liver immunology, and liver diseases. Cellular & Molecular Immunology. PMID 33318628 DOI: 10.1038/s41423-020-00592-6 |
0.504 |
|
| 2020 |
Sharpton SR, Schnabl B, Knight R, Loomba R. Current Concepts, Opportunities, and Challenges of Gut Microbiome-Based Personalized Medicine in Nonalcoholic Fatty Liver Disease. Cell Metabolism. PMID 33296678 DOI: 10.1016/j.cmet.2020.11.010 |
0.418 |
|
| 2020 |
Lang S, Demir M, Schnabl B. Targeting pathobionts for the treatment of alcohol-associated liver disease. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 33159427 DOI: 10.1111/liv.14723 |
0.425 |
|
| 2020 |
Jiang L, Stärkel P, Fan JG, Fouts DE, Bacher P, Schnabl B. The gut mycobiome: a novel player in chronic liver diseases. Journal of Gastroenterology. PMID 33151407 DOI: 10.1007/s00535-020-01740-5 |
0.367 |
|
| 2020 |
Tranah TH, Edwards LA, Schnabl B, Shawcross DL. Targeting the gut-liver-immune axis to treat cirrhosis. Gut. PMID 33060124 DOI: 10.1136/gutjnl-2020-320786 |
0.394 |
|
| 2020 |
Bluemel S, Wang Y, Lee S, Schnabl B. Tumor necrosis factor alpha receptor 1 deficiency in hepatocytes does not protect from non-alcoholic steatohepatitis, but attenuates insulin resistance in mice. World Journal of Gastroenterology. 26: 4933-4944. PMID 32952340 DOI: 10.3748/Wjg.V26.I33.4933 |
0.501 |
|
| 2020 |
Mendes BG, Schnabl B. From intestinal dysbiosis to alcohol-associated liver disease. Clinical and Molecular Hepatology. PMID 32911590 DOI: 10.3350/Cmh.2020.0086 |
0.538 |
|
| 2020 |
Lang S, Schnabl B. Microbiota and Fatty Liver Disease-the Known, the Unknown, and the Future. Cell Host & Microbe. 28: 233-244. PMID 32791115 DOI: 10.1016/J.Chom.2020.07.007 |
0.599 |
|
| 2020 |
Gao B, Duan Y, Lang S, Barupal D, Wu TC, Valdiviez L, Roberts B, Choy YY, Shen T, Byram G, Zhang Y, Fan S, Wancewicz B, Shao Y, Vervier K, ... ... Schnabl B, et al. Functional Microbiomics Reveals Alterations of the Gut Microbiome and Host Co-Metabolism in Patients With Alcoholic Hepatitis. Hepatology Communications. 4: 1168-1182. PMID 32766476 DOI: 10.1002/hep4.1537 |
0.376 |
|
| 2020 |
Lang S, Fairfied B, Gao B, Duan Y, Zhang X, Fouts DE, Schnabl B. Changes in the fecal bacterial microbiota associated with disease severity in alcoholic hepatitis patients. Gut Microbes. 1-12. PMID 32684075 DOI: 10.1080/19490976.2020.1785251 |
0.529 |
|
| 2020 |
Jiang L, Chu H, Gao B, Lang S, Wang Y, Duan Y, Schnabl B. Transcriptomic Profiling Identifies Novel Hepatic and Intestinal Genes Following Chronic Plus Binge Ethanol Feeding in Mice. Digestive Diseases and Sciences. PMID 32671585 DOI: 10.1007/S10620-020-06461-6 |
0.543 |
|
| 2020 |
Jiang L, Lang S, Duan Y, Zhang X, Gao B, Chopyk J, Schwanemann LK, Ventura-Cots M, Bataller R, Bosques-Padilla F, Verna EC, Abraldes JG, Brown RS, Vargas V, Altamirano J, ... ... Schnabl B, et al. Intestinal virome in patients with alcoholic hepatitis. Hepatology (Baltimore, Md.). PMID 32654263 DOI: 10.1002/Hep.31459 |
0.625 |
|
| 2020 |
Lang S, Demir M, Martin A, Jiang L, Zhang X, Duan Y, Gao B, Wisplinghoff H, Kasper P, Roderburg C, Tacke F, Steffen HM, Goeser T, Abraldes JG, Tu XM, ... ... Schnabl B, et al. Intestinal Virome Signature Associated With Severity of Nonalcoholic Fatty Liver Disease. Gastroenterology. PMID 32652145 DOI: 10.1053/J.Gastro.2020.07.005 |
0.55 |
|
| 2020 |
Zhou R, Llorente C, Cao J, Gao B, Duan Y, Jiang L, Wang Y, Kumar V, Stärkel P, Bode L, Fan X, Schnabl B. Deficiency of Intestinal α1-2-fucosylation Exacerbates Ethanol-Induced Liver Disease in Mice. Alcoholism, Clinical and Experimental Research. PMID 32628772 DOI: 10.1111/Acer.14405 |
0.556 |
|
| 2020 |
Maccioni L, Gao B, Leclercq S, Pirlot B, Horsmans Y, De Timary P, Leclercq I, Fouts D, Schnabl B, Stärkel P. Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans. Gut Microbes. 1-23. PMID 32588725 DOI: 10.1080/19490976.2020.1782157 |
0.576 |
|
| 2020 |
Gao B, Emami A, Nath S, Schnabl B. Microbial Products and Metabolites Contributing to Alcohol-Related Liver Disease. Molecular Nutrition & Food Research. e2000023. PMID 32583604 DOI: 10.1002/Mnfr.202000023 |
0.576 |
|
| 2020 |
Chu H, Jiang L, Gao B, Gautam N, Alamoudi JA, Lang S, Wang Y, Duan Y, Alnouti Y, Cable EE, Schnabl B. The selective PPAR-delta agonist seladelpar reduces ethanol-induced liver disease by restoring gut barrier function and bile acid homeostasis in mice. Translational Research : the Journal of Laboratory and Clinical Medicine. PMID 32553670 DOI: 10.1016/J.Trsl.2020.06.006 |
0.463 |
|
| 2020 |
Jiang L, Schnabl B. Gut Microbiota in Liver Disease: What Do We Know and What Do We Not Know? Physiology (Bethesda, Md.). 35: 261-274. PMID 32490750 DOI: 10.1152/Physiol.00005.2020 |
0.596 |
|
| 2020 |
Gao B, Emami A, Zhou R, Lang S, Duan Y, Wang Y, Jiang L, Loomba R, Brenner DA, Stärkel P, Schnabl B. Functional Microbial Responses to Alcohol Abstinence in Patients With Alcohol Use Disorder. Frontiers in Physiology. 11: 370. PMID 32390870 DOI: 10.3389/Fphys.2020.00370 |
0.552 |
|
| 2020 |
Bajic D, Niemann A, Hillmer AK, Mejias-Luque R, Bluemel S, Docampo M, Funk MC, Tonin E, Boutros M, Schnabl B, Busch DH, Miki T, Schmid RM, van den Brink MRM, Gerhard M, et al. Gut microbiota derived propionate regulates the expression of Reg3 mucosal lectins and ameliorates experimental colitis in mice. Journal of Crohn's & Colitis. PMID 32227170 DOI: 10.1093/Ecco-Jcc/Jjaa065 |
0.301 |
|
| 2020 |
Neuman MG, Seitz HK, French SW, Malnick S, Tsukamoto H, Cohen LB, Hoffman P, Tabakoff B, Fasullo M, Nagy LE, Tuma PL, Schnabl B, Mueller S, Groebner JL, Barbara FA, et al. Alcoholic-Hepatitis, Links to Brain and Microbiome: Mechanisms, Clinical and Experimental Research. Biomedicines. 8. PMID 32197424 DOI: 10.3390/Biomedicines8030063 |
0.553 |
|
| 2020 |
Marrero I, Maricic I, Morgan TR, Stolz AA, Schnabl B, Liu ZX, Tsukamoto H, Kumar V. Differential activation of unconventional T cells, including iNKT cells, in alcohol-related liver disease. Alcoholism, Clinical and Experimental Research. PMID 32154597 DOI: 10.1111/Acer.14323 |
0.465 |
|
| 2020 |
Lang S, Demir M, Duan Y, Martin A, Schnabl B. Cytolysin-positive Enterococcus faecalis is not increased in patients with non-alcoholic steatohepatitis. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 31943701 DOI: 10.1111/Liv.14377 |
0.584 |
|
| 2020 |
Fairfield BS, Lang S, Gao B, Fouts DE, Schnabl B. Su1595 CHANGES IN GUT MICROBIOME IN PATIENTS WITH ALCOHOLIC HEPATITIS: HOW DISEASE SEVERITY CORRELATES WITH REDUCED MICROBIOTA DIVERSITY Gastroenterology. 158. DOI: 10.1016/S0016-5085(20)34048-8 |
0.487 |
|
| 2019 |
Avila MA, Dufour JF, Gerbes AL, Zoulim F, Bataller R, Burra P, Cortez-Pinto H, Gao B, Gilmore I, Mathurin P, Moreno C, Poznyak V, Schnabl B, Szabo G, Thiele M, et al. Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting. Gut. PMID 31879281 DOI: 10.1136/Gutjnl-2019-319720 |
0.547 |
|
| 2019 |
Duan Y, Llorente C, Lang S, Brandl K, Chu H, Jiang L, White RC, Clarke TH, Nguyen K, Torralba M, Shao Y, Liu J, Hernandez-Morales A, Lessor L, Rahman IR, ... ... Schnabl B, et al. Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease. Nature. PMID 31723265 DOI: 10.1038/S41586-019-1742-X |
0.575 |
|
| 2019 |
Furuya S, Argemi J, Uehara T, Katou Y, Fouts DE, Schnabl B, Dubuquoy L, Belorkar A, Vadigepalli R, Kono H, Bataller R, Rusyn I. A novel mouse model of acute-on-chronic cholestatic alcoholic liver disease: A systems biology comparison with human alcoholic hepatitis. Alcoholism, Clinical and Experimental Research. PMID 31710124 DOI: 10.1111/Acer.14234 |
0.554 |
|
| 2019 |
Chu H, Duan Y, Lang S, Jiang L, Wang Y, Llorente C, Liu J, Mogavero S, Bosques-Padilla F, Abraldes JG, Vargas V, Tu XM, Yang L, Hou X, Hube B, ... ... Schnabl B, et al. The Candida albicans exotoxin Candidalysin promotes alcohol-associated liver disease. Journal of Hepatology. PMID 31606552 DOI: 10.1016/J.Jhep.2019.09.029 |
0.575 |
|
| 2019 |
Loomba R, Seguritan V, Li W, Long T, Klitgord N, Bhatt A, Dulai PS, Caussy C, Bettencourt R, Highlander SK, Jones MB, Sirlin CB, Schnabl B, Brinkac L, Schork N, et al. Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease. Cell Metabolism. 30: 607. PMID 31484056 DOI: 10.1016/j.cmet.2019.08.002 |
0.568 |
|
| 2019 |
Stärkel P, Schnabl B, Leclercq S, Komuta M, Bataller R, Argemi J, Palma E, Chokshi S, Hellerbrand C, Maccioni L, Lanthier N, Leclercq I. Deficient IL-6/Stat3 Signaling, High TLR7, and Type I Interferons in Early Human Alcoholic Liver Disease: A Triad for Liver Damage and Fibrosis. Hepatology Communications. 3: 867-882. PMID 31334440 DOI: 10.1002/hep4.1364 |
0.493 |
|
| 2019 |
Wang L, Mazagova M, Pan C, Yang S, Brandl K, Liu J, Reilly SM, Wang Y, Miao Z, Loomba R, Lu N, Guo Q, Liu J, Yu RT, Downes M, ... ... Schnabl B, et al. YIPF6 controls sorting of FGF21 into COPII vesicles and promotes obesity. Proceedings of the National Academy of Sciences of the United States of America. PMID 31289229 DOI: 10.1073/Pnas.1904360116 |
0.526 |
|
| 2019 |
Lang S, Duan Y, Liu J, Torralba MG, Kuelbs C, Ventura-Cots M, Abraldes JG, Bosques-Padilla F, Verna EC, Brown RS, Vargas V, Altamirano J, Caballería J, Shawcross D, Lucey MR, ... ... Schnabl B, et al. Intestinal fungal dysbiosis and systemic immune response to fungi in patients with alcoholic hepatitis. Hepatology (Baltimore, Md.). PMID 31228214 DOI: 10.1002/Hep.30832 |
0.463 |
|
| 2019 |
Gao B, Lang S, Duan Y, Wang Y, Shawcross DL, Louvet A, Mathurin P, Ho SB, Stärkel P, Schnabl B. Serum and Fecal Oxylipins in Patients with Alcohol-Related Liver Disease. Digestive Diseases and Sciences. PMID 31076986 DOI: 10.1007/S10620-019-05638-Y |
0.567 |
|
| 2019 |
Bluemel S, Wang L, Kuelbs C, Moncera K, Torralba M, Singh H, Fouts DE, Schnabl B. Intestinal and hepatic microbiota changes associated with chronic ethanol administration in mice. Gut Microbes. 1-11. PMID 30982395 DOI: 10.1080/19490976.2019.1595300 |
0.543 |
|
| 2019 |
Hendrikx T, Schnabl B. Indoles: metabolites produced by intestinal bacteria capable of controlling liver disease manifestation. Journal of Internal Medicine. 286: 32-40. PMID 30873652 DOI: 10.1111/Joim.12892 |
0.544 |
|
| 2019 |
Zhou R, Fan X, Schnabl B. Role of the intestinal microbiome in liver fibrosis development and new treatment strategies. Translational Research : the Journal of Laboratory and Clinical Medicine. PMID 30853445 DOI: 10.1016/J.Trsl.2019.02.005 |
0.607 |
|
| 2019 |
Lee KC, Chen P, Maricic I, Inamine T, Hu J, Gong S, Sun JC, Dasgupta S, Lin HC, Lin YT, Loomba R, Stärkel P, Kumar V, Schnabl B. Intestinal iNKT Cells Migrate to Liver and Contribute to Hepatocyte Apoptosis During Alcoholic Liver Disease. American Journal of Physiology. Gastrointestinal and Liver Physiology. PMID 30817180 DOI: 10.1152/Ajpgi.00269.2018 |
0.55 |
|
| 2019 |
Fu T, Coulter S, Yoshihara E, Oh TG, Fang S, Cayabyab F, Zhu Q, Zhang T, Leblanc M, Liu S, He M, Waizenegger W, Gasser E, Schnabl B, Atkins AR, et al. FXR Regulates Intestinal Cancer Stem Cell Proliferation. Cell. 176: 1098-1112.e18. PMID 30794774 DOI: 10.1016/J.Cell.2019.01.036 |
0.314 |
|
| 2019 |
Hartmann P, Chu H, Duan Y, Schnabl B. Gut microbiota in liver disease: Too much is harmful, nothing at all is not helpful either. American Journal of Physiology. Gastrointestinal and Liver Physiology. PMID 30767680 DOI: 10.1152/Ajpgi.00370.2018 |
0.606 |
|
| 2019 |
Sarin SK, Pande A, Schnabl B. Microbiome as a therapeutic target in alcohol-related liver disease. Journal of Hepatology. 70: 260-272. PMID 30658727 DOI: 10.1016/J.Jhep.2018.10.019 |
0.585 |
|
| 2019 |
Hendrikx T, Schnabl B. Antimicrobial proteins: intestinal guards to protect against liver disease. Journal of Gastroenterology. 54: 209-217. PMID 30392013 DOI: 10.1007/S00535-018-1521-8 |
0.6 |
|
| 2019 |
Lang S, Duan Y, Liu J, Ventura-Cots M, Lucey MR, Padilla FJB, Mathurin P, Louvet A, Garcia-Tsao G, Verna EC, Abraldes J, Brown RS, Vargas V, Altamirano J, Caballería J, ... ... Schnabl B, et al. 246 – Intestinal Fungal Dysbiosis and Systemic Immune Response to Fungi in Patients with Alcoholic Hepatitis Gastroenterology. 156. DOI: 10.1016/S0016-5085(19)39939-1 |
0.424 |
|
| 2018 |
Caussy C, Hsu C, Singh S, Bassirian S, Kolar J, Faulkner C, Sinha N, Bettencourt R, Gara N, Valasek MA, Schnabl B, Richards L, Brenner DA, Hofmann AF, Loomba R. Serum bile acid patterns are associated with the presence of NAFLD in twins, and dose-dependent changes with increase in fibrosis stage in patients with biopsy-proven NAFLD. Alimentary Pharmacology & Therapeutics. PMID 30506692 DOI: 10.1111/Apt.15035 |
0.601 |
|
| 2018 |
Gong S, Yan Z, Liu Z, Niu M, Fang H, Li N, Huang C, Li L, Chen G, Luo H, Chen X, Zhou H, Hu J, Yang W, Huang Q, ... Schnabl B, et al. Intestinal microbiota mediates the susceptibility to polymicrobial sepsis-induced liver injury by granisetron generation in mice. Hepatology (Baltimore, Md.). PMID 30506577 DOI: 10.1002/Hep.30361 |
0.483 |
|
| 2018 |
Hendrikx T, Duan Y, Wang Y, Oh JH, Alexander LM, Huang W, Stärkel P, Ho SB, Gao B, Fiehn O, Emond P, Sokol H, van Pijkeren JP, Schnabl B. Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice. Gut. PMID 30448775 DOI: 10.1136/Gutjnl-2018-317232 |
0.505 |
|
| 2018 |
Chu H, Williams B, Schnabl B. Gut microbiota, fatty liver disease, and hepatocellular carcinoma. Liver Research. 2: 43-51. PMID 30416839 DOI: 10.1016/J.Livres.2017.11.005 |
0.522 |
|
| 2018 |
Brandl K, Hartmann P, Jih LJ, Pizzo DP, Schnabl B. What is the cellular source of FGF19 during chronic liver disease? Journal of Hepatology. PMID 30301625 DOI: 10.1016/J.Jhep.2018.09.017 |
0.487 |
|
| 2018 |
Marrero I, Maricic I, Feldstein AE, Loomba R, Schnabl B, Rivera-Nieves J, Eckmann L, Kumar V. Complex Network of NKT Cell Subsets Controls Immune Homeostasis in Liver and Gut. Frontiers in Immunology. 9: 2082. PMID 30254647 DOI: 10.3389/Fimmu.2018.02082 |
0.47 |
|
| 2018 |
Allaband C, McDonald D, Vázquez-Baeza Y, Minich JJ, Tripathi A, Brenner DA, Loomba R, Smarr L, Sandborn WJ, Schnabl B, Dorrestein P, Zarrinpar A, Knight R. Microbiome 101: Studying, Analyzing, and Interpreting Gut Microbiome Data for Clinicians. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 30240894 DOI: 10.1016/J.Cgh.2018.09.017 |
0.439 |
|
| 2018 |
Chu H, Duan Y, Yang L, Schnabl B. Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease. Gut. PMID 30171065 DOI: 10.1136/Gutjnl-2018-316307 |
0.561 |
|
| 2018 |
Tripathi A, Debelius J, Brenner DA, Karin M, Loomba R, Schnabl B, Knight R. Publisher Correction: The gut-liver axis and the intersection with the microbiome. Nature Reviews. Gastroenterology & Hepatology. PMID 29785003 DOI: 10.1038/S41575-018-0031-8 |
0.665 |
|
| 2018 |
Tripathi A, Debelius J, Brenner DA, Karin M, Loomba R, Schnabl B, Knight R. The gut-liver axis and the intersection with the microbiome. Nature Reviews. Gastroenterology & Hepatology. PMID 29748586 DOI: 10.1038/S41575-018-0011-Z |
0.675 |
|
| 2018 |
Chen Y, Ouyang X, Hoque R, Garcia-Martinez I, Yousaf MN, Tonack S, Offermanns S, Dubuquoy L, Louvet A, Mathurin P, Massey V, Schnabl B, Bataller RA, Mehal WZ. B-hydroxybutyrate protects from alcohol-induced liver injury via a Hcar2-cAMP dependent pathway. Journal of Hepatology. PMID 29705237 DOI: 10.1016/J.Jhep.2018.04.004 |
0.495 |
|
| 2018 |
Brandl K, Hartmann P, Jih LJ, Pizzo DP, Argemi J, Ventura-Cots M, Coulter S, Liddle C, Ling L, Rossi SJ, DePaoli AM, Loomba R, Mehal WZ, Fouts DE, Lucey MR, ... ... Schnabl B, et al. Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis. Journal of Hepatology. PMID 29654817 DOI: 10.1016/J.Jhep.2018.03.031 |
0.472 |
|
| 2018 |
Bluemel S, Wang L, Martino C, Lee S, Wang Y, Williams B, Horvath A, Stadlbauer V, Zengler K, Schnabl B. The Role of Intestinal C-type Regenerating Islet Derived-3 Lectins for Nonalcoholic Steatohepatitis. Hepatology Communications. 2: 393-406. PMID 29619418 DOI: 10.1002/hep4.1165 |
0.421 |
|
| 2018 |
Caussy C, Hsu C, Lo MT, Liu A, Bettencourt R, Ajmera VH, Bassirian S, Hooker J, Sy E, Richards L, Schork N, Schnabl B, Brenner DA, Sirlin CB, Chen CH, et al. Novel link between gut-microbiome derived metabolite and shared gene-effects with hepatic steatosis and fibrosis in NAFLD. Hepatology (Baltimore, Md.). PMID 29572891 DOI: 10.1002/Hep.29892 |
0.594 |
|
| 2018 |
Gong S, Lan T, Zeng L, Luo H, Yang X, Li N, Chen X, Liu Z, Li R, Win S, Liu S, Zhou H, Schnabl B, Jiang Y, Kaplowitz N, et al. Gut microbiota mediates diurnal variation of acetaminophen induced acute liver injury in mice. Journal of Hepatology. PMID 29524531 DOI: 10.1016/J.Jhep.2018.02.024 |
0.483 |
|
| 2018 |
Ouyang X, Han SN, Zhang JY, Nemeth BT, Pacher P, Feng D, Bataller R, Cabezas J, Stärkel P, Caballeria J, Pongratz RL, Cai SY, Schnabl B, Hoque R, Chen Y, et al. Digoxin Suppresses Pyruvate Kinase M2-Promoted HIF-1α Transactivation in Steatohepatitis. Cell Metabolism. 27: 339-350.e3. PMID 29414684 DOI: 10.1016/J.Cmet.2018.01.007 |
0.515 |
|
| 2018 |
Stärkel P, Leclercq S, de Timary P, Schnabl B. Intestinal dysbiosis and permeability: the yin and yang in alcohol dependence and alcoholic liver disease. Clinical Science (London, England : 1979). 132: 199-212. PMID 29352076 DOI: 10.1042/Cs20171055 |
0.556 |
|
| 2018 |
Inamine T, Schnabl B. Immunoglobulin A and liver diseases. Journal of Gastroenterology. 53: 691-700. PMID 29075899 DOI: 10.1007/S00535-017-1400-8 |
0.606 |
|
| 2018 |
Hochrath K, Schnabl B. Check your microbiota when taking the drug. Hepatology (Baltimore, Md.). 67: 18-20. PMID 28782199 DOI: 10.1002/Hep.29422 |
0.392 |
|
| 2017 |
Llorente C, Jepsen P, Inamine T, Wang L, Bluemel S, Wang HJ, Loomba R, Bajaj JS, Schubert ML, Sikaroodi M, Gillevet PM, Xu J, Kisseleva T, Ho SB, DePew J, ... ... Schnabl B, et al. Publisher Correction: Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus. Nature Communications. 8: 2137. PMID 29233961 DOI: 10.1038/S41467-017-01779-8 |
0.585 |
|
| 2017 |
Hartmann P, Hochrath K, Horvath A, Chen P, Seebauer CT, Llorente C, Wang L, Alnouti Y, Fouts DE, Stärkel P, Loomba R, Coulter S, Liddle C, Yu RT, Ling L, ... ... Schnabl B, et al. Modulation of the intestinal bile acid-FXR-FGF15 axis improves alcoholic liver disease in mice. Hepatology (Baltimore, Md.). PMID 29159825 DOI: 10.1002/Hep.29676 |
0.658 |
|
| 2017 |
Wang W, Zhao J, Gui W, Sun D, Dai H, Xiao L, Chu H, Du F, Zhu Q, Schnabl B, Huang K, Yang L, Hou X. Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in NAFLD mice. British Journal of Pharmacology. PMID 29139555 DOI: 10.1111/Bph.14095 |
0.55 |
|
| 2017 |
Boule LA, Ju C, Agudelo M, Parira T, Cannon A, Davis B, Eby J, Cresci G, Samuelson DR, Shukla P, Alrefai WA, Sureshchandra S, Pandey SC, Schnabl B, Curtis BJ, et al. Summary of the 2016 Alcohol and Immunology Research Interest Group (AIRIG) meeting. Alcohol (Fayetteville, N.Y.). 66: 35-43. PMID 29127885 DOI: 10.1016/J.Alcohol.2017.07.005 |
0.387 |
|
| 2017 |
Khanova E, Wu R, Wang W, Yan R, Chen Y, French SW, Llorente C, Pan SQ, Yang Q, Li Y, Lazaro R, Ansong C, Smith RD, Bataller R, Morgan T, ... Schnabl B, et al. Pyroptosis by Caspase11/4-Gasdermin-D Pathway in Alcoholic Hepatitis. Hepatology (Baltimore, Md.). PMID 29108122 DOI: 10.1002/Hep.29645 |
0.568 |
|
| 2017 |
Hendrikx T, Schnabl B. Lamin Deficiency in the Liver Sets the Stage for Nonalcoholic Steatohepatitis Development in Males. Cellular and Molecular Gastroenterology and Hepatology. 4: 441-442. PMID 29062878 DOI: 10.1016/J.Jcmgh.2017.09.002 |
0.426 |
|
| 2017 |
Llorente C, Jepsen P, Inamine T, Wang L, Bluemel S, Wang HJ, Loomba R, Bajaj JS, Schubert ML, Sikaroodi M, Gillevet PM, Xu J, Kisseleva T, Ho SB, DePew J, ... ... Schnabl B, et al. Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus. Nature Communications. 8: 837. PMID 29038503 DOI: 10.1038/S41467-017-00796-X |
0.692 |
|
| 2017 |
Yang AM, Inamine T, Hochrath K, Chen P, Wang L, Llorente C, Bluemel S, Hartmann P, Xu J, Koyama Y, Kisseleva T, Torralba MG, Moncera K, Beeri K, Chen CS, ... ... Schnabl B, et al. Intestinal fungi contribute to development of alcoholic liver disease. The Journal of Clinical Investigation. PMID 28530644 DOI: 10.1172/Jci90562 |
0.57 |
|
| 2017 |
Loomba R, Seguritan V, Li W, Long T, Klitgord N, Bhatt A, Dulai PS, Caussy C, Bettencourt R, Highlander SK, Jones MB, Sirlin CB, Schnabl B, Brinkac L, Schork N, et al. Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease. Cell Metabolism. 25: 1054-1062.e5. PMID 28467925 DOI: 10.1016/J.Cmet.2017.04.001 |
0.615 |
|
| 2017 |
Brandl K, Schnabl B. Intestinal microbiota and nonalcoholic steatohepatitis. Current Opinion in Gastroenterology. PMID 28257306 DOI: 10.1097/Mog.0000000000000349 |
0.538 |
|
| 2017 |
Schnabl B. Mucosa-associated bacteria as a therapeutic target of alcoholic liver disease Alcohol. 59: 75. DOI: 10.1016/J.Alcohol.2016.10.032 |
0.534 |
|
| 2016 |
Stärkel P, Schnabl B. Bidirectional Communication between Liver and Gut during Alcoholic Liver Disease. Seminars in Liver Disease. 36: 331-339. PMID 27997973 DOI: 10.1055/S-0036-1593882 |
0.586 |
|
| 2016 |
Inamine T, Yang AM, Wang L, Lee KC, Llorente C, Schnabl B. Genetic Loss of Immunoglobulin A Does Not Influence Development of Alcoholic Steatohepatitis in Mice. Alcoholism, Clinical and Experimental Research. PMID 27739086 DOI: 10.1111/Acer.13239 |
0.482 |
|
| 2016 |
Patel NS, Hooker J, Gonzalez M, Bhatt A, Nguyen P, Ramirez K, Richards L, Rizo E, Hernandez C, Kisseleva T, Schnabl B, Brenner D, Sirlin CB, Loomba R. Weight loss decreases magnetic resonance elastography estimated liver stiffness in nonalcoholic fatty liver disease. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 27712981 DOI: 10.1016/J.Cgh.2016.09.150 |
0.571 |
|
| 2016 |
Bluemel S, Williams B, Knight R, Schnabl B. Precision Medicine in Alcoholic and Non-Alcoholic Fatty Liver Disease via Modulating the Gut Microbiota. American Journal of Physiology. Gastrointestinal and Liver Physiology. ajpgi.00245.2016. PMID 27686615 DOI: 10.1152/Ajpgi.00245.2016 |
0.584 |
|
| 2016 |
Eguchi A, Lazaro RG, Wang J, Kim J, Povero D, Willliams B, Ho SB, Stärkel P, Schnabl B, Ohno-Machado L, Tsukamoto H, Feldstein AE. Extracellular vesicles released by hepatocytes from gastric infusion model of ALD contain a miRNA barcode that can be detected in blood. Hepatology (Baltimore, Md.). PMID 27639178 DOI: 10.1002/Hep.28838 |
0.322 |
|
| 2016 |
Llorente C, Schnabl B. Fast-Track Clearance of Bacteria from the Liver. Cell Host & Microbe. 20: 1-2. PMID 27414492 DOI: 10.1016/J.Chom.2016.06.012 |
0.417 |
|
| 2016 |
Chen P, Miyamoto Y, Mazagova M, Lee KC, Eckmann L, Schnabl B. Microbiota and Alcoholic Liver Disease. Alcoholism, Clinical and Experimental Research. PMID 27364225 DOI: 10.1111/Acer.13129 |
0.563 |
|
| 2016 |
Arroyo V, Moreau R, Kamath PS, Jalan R, Ginès P, Nevens F, Fernández J, To U, García-Tsao G, Schnabl B. Acute-on-chronic liver failure in cirrhosis. Nature Reviews. Disease Primers. 2: 16041. PMID 27277335 DOI: 10.1038/nrdp.2016.41 |
0.314 |
|
| 2016 |
Nakamoto N, Schnabl B. Does the Intestinal Microbiota Explain Differences in the Epidemiology of Liver Disease between East and West? Inflammatory Intestinal Diseases. 1: 3-8. PMID 27243019 DOI: 10.1159/000443196 |
0.456 |
|
| 2016 |
Fuchs M, Schnabl B. Editors' Introduction to the NAFLD and NASH Special Issue. Digestive Diseases and Sciences. 61: 1211-3. PMID 27068170 DOI: 10.1007/S10620-016-4152-Z |
0.358 |
|
| 2016 |
Schnabl B, Farshchi-Heydari S, Loomba R, Mattrey RF, Hoh CK, Sirlin CB, Brenner DA, Behling CA, Vera DR. Staging of fibrosis in experimental non-alcoholic steatohepatitis by quantitative molecular imaging in rat models. Nuclear Medicine and Biology. 43: 179-87. PMID 26872443 DOI: 10.1016/J.Nucmedbio.2015.11.009 |
0.547 |
|
| 2016 |
Wang L, Fouts DE, Stärkel P, Hartmann P, Chen P, Llorente C, DePew J, Moncera K, Ho SB, Brenner DA, Hooper LV, Schnabl B. Intestinal REG3 Lectins Protect against Alcoholic Steatohepatitis by Reducing Mucosa-Associated Microbiota and Preventing Bacterial Translocation. Cell Host & Microbe. 19: 227-39. PMID 26867181 DOI: 10.1016/J.Chom.2016.01.003 |
0.657 |
|
| 2016 |
Schnabl B. Liver capsule: Mechanisms of alcoholic hepatitis. Hepatology (Baltimore, Md.). 64: 276. PMID 26867027 DOI: 10.1002/Hep.28488 |
0.553 |
|
| 2016 |
Horvath A, Hartmann P, Schnabl B, Stadlbauer V. Alcohol consumption and liver damage: A balancing act for the innate immune system Zeitschrift FüR Gastroenterologie. 54. DOI: 10.1055/S-0036-1584061 |
0.389 |
|
| 2016 |
Patel NS, Hooker J, Gonzalez M, Bhatt A, Nguyen P, Ramirez K, Richards L, Rizo E, Hernandez C, Kisseleva T, Schnabl B, Brenner DA, Sirlin CB, Loomba R. Mo1542 Effect of Weight Loss on MRE Estimated Stiffness in Patients With Nonalcoholic Fatty Liver Disease Gastroenterology. 150. DOI: 10.1016/S0016-5085(16)33846-X |
0.565 |
|
| 2016 |
Schnabl B, Farshchi-Heydari S, Loomba R, Mattrey RF, Hoh CK, Sirlin CB, Brenner DA, Behling CA, Vera DR. Staging of fibrosis in experimental non-alcoholic steatohepatitis by quantitative molecular imaging in rat models Nuclear Medicine and Biology. 43: 179-187. DOI: 10.1016/j.nucmedbio.2015.11.009 |
0.444 |
|
| 2015 |
Hartmann P, Seebauer CT, Mazagova M, Horvath A, Wang L, Llorente C, Varki NM, Brandl K, Ho SB, Schnabl B. Deficiency of intestinal mucin-2 protects mice from diet-induced fatty liver disease and obesity. American Journal of Physiology. Gastrointestinal and Liver Physiology. ajpgi.00094.2015. PMID 26702135 DOI: 10.1152/Ajpgi.00094.2015 |
0.491 |
|
| 2015 |
Chen P, Miyamoto Y, Mazagova M, Lee KC, Eckmann L, Schnabl B. Microbiota Protects Mice Against Acute Alcohol-Induced Liver Injury. Alcoholism, Clinical and Experimental Research. PMID 26556636 DOI: 10.1111/Acer.12900 |
0.561 |
|
| 2015 |
Brenner DA, Paik YH, Schnabl B. Role of Gut Microbiota in Liver Disease. Journal of Clinical Gastroenterology. 49: S25-7. PMID 26447960 DOI: 10.1097/Mcg.0000000000000391 |
0.668 |
|
| 2015 |
Bernardi M, Moreau R, Angeli P, Schnabl B, Arroyo V. Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis. Journal of Hepatology. 63: 1272-84. PMID 26192220 DOI: 10.1016/J.Jhep.2015.07.004 |
0.325 |
|
| 2015 |
Llorente C, Schnabl B. The gut microbiota and liver disease. Cellular and Molecular Gastroenterology and Hepatology. 1: 275-284. PMID 26090511 DOI: 10.1016/J.Jcmgh.2015.04.003 |
0.519 |
|
| 2015 |
Brandl K, Schnabl B. Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease? Expert Review of Gastroenterology & Hepatology. 9: 1069-76. PMID 26088524 DOI: 10.1586/17474124.2015.1057122 |
0.514 |
|
| 2015 |
Hartmann P, Seebauer CT, Schnabl B. Alcoholic liver disease: the gut microbiome and liver cross talk. Alcoholism, Clinical and Experimental Research. 39: 763-75. PMID 25872593 DOI: 10.1111/Acer.12704 |
0.584 |
|
| 2015 |
Arulanandan A, Ang B, Bettencourt R, Hooker J, Behling C, Lin GY, Valasek MA, Ix JH, Schnabl B, Sirlin CB, Loomba R. Association Between Quantity of Liver Fat and Cardiovascular Risk in Patients With Nonalcoholic Fatty Liver Disease Independent of Nonalcoholic Steatohepatitis. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 25661453 DOI: 10.1016/J.Cgh.2015.01.027 |
0.52 |
|
| 2015 |
Wang L, Llorente C, Hartmann P, Yang AM, Chen P, Schnabl B. Methods to determine intestinal permeability and bacterial translocation during liver disease. Journal of Immunological Methods. 421: 44-53. PMID 25595554 DOI: 10.1016/J.Jim.2014.12.015 |
0.53 |
|
| 2015 |
Fang S, Suh JM, Reilly SM, Yu E, Osborn O, Lackey D, Yoshihara E, Perino A, Jacinto S, Lukasheva Y, Atkins AR, Khvat A, Schnabl B, Yu RT, Brenner DA, et al. Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance. Nature Medicine. 21: 159-65. PMID 25559344 DOI: 10.1038/Nm.3760 |
0.523 |
|
| 2015 |
Mazagova M, Wang L, Anfora AT, Wissmueller M, Lesley SA, Miyamoto Y, Eckmann L, Dhungana S, Pathmasiri W, Sumner S, Westwater C, Brenner DA, Schnabl B. Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 29: 1043-55. PMID 25466902 DOI: 10.1096/Fj.14-259515 |
0.658 |
|
| 2015 |
Chen P, Stärkel P, Turner JR, Ho SB, Schnabl B. Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice. Hepatology (Baltimore, Md.). 61: 883-94. PMID 25251280 DOI: 10.1002/Hep.27489 |
0.538 |
|
| 2015 |
Chen P, Torralba M, Tan J, Embree M, Zengler K, Stärkel P, van Pijkeren JP, DePew J, Loomba R, Ho SB, Bajaj JS, Mutlu EA, Keshavarzian A, Tsukamoto H, Nelson KE, ... ... Schnabl B, et al. Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice. Gastroenterology. 148: 203-214.e16. PMID 25239591 DOI: 10.1053/J.Gastro.2014.09.014 |
0.579 |
|
| 2015 |
Patel NS, Doycheva I, Peterson MR, Hooker J, Kisselva T, Schnabl B, Seki E, Sirlin CB, Loomba R. Effect of weight loss on magnetic resonance imaging estimation of liver fat and volume in patients with nonalcoholic steatohepatitis. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 13: 561-568.e1. PMID 25218667 DOI: 10.1016/J.Cgh.2014.08.039 |
0.425 |
|
| 2014 |
Schnabl B. The Microbiome and the Liver. Gastroenterology & Hepatology. 10: 519-521. PMID 28845144 |
0.449 |
|
| 2014 |
Chen P, Schnabl B. Host-microbiome interactions in alcoholic liver disease. Gut and Liver. 8: 237-41. PMID 24827618 DOI: 10.5009/Gnl.2014.8.3.237 |
0.567 |
|
| 2014 |
Wang L, Hartmann P, Haimerl M, Bathena SP, Sjöwall C, Almer S, Alnouti Y, Hofmann AF, Schnabl B. Nod2 deficiency protects mice from cholestatic liver disease by increasing renal excretion of bile acids. Journal of Hepatology. 60: 1259-67. PMID 24560660 DOI: 10.1016/J.Jhep.2014.02.012 |
0.512 |
|
| 2014 |
Jalan R, Fernandez J, Wiest R, Schnabl B, Moreau R, Angeli P, Stadlbauer V, Gustot T, Bernardi M, Canton R, Albillos A, Lammert F, Wilmer A, Mookerjee R, Vila J, et al. Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. Journal of Hepatology. 60: 1310-24. PMID 24530646 DOI: 10.1016/J.Jhep.2014.01.024 |
0.338 |
|
| 2014 |
Schnabl B, Brenner DA. Interactions between the intestinal microbiome and liver diseases Gastroenterology. 146: 1513-1524. PMID 24440671 DOI: 10.1053/J.Gastro.2014.01.020 |
0.678 |
|
| 2014 |
Chen P, Torralba M, Zengler K, Mutlu E, Keshavarzian A, Tsukamoto H, Nelson KE, Brenner DA, Fouts DE, Schnabl B. 387 Restoration of Intestinal Metabolic Homeostasis Results in Eubiosis and Protects Mice From Alcoholic Liver Disease Gastroenterology. 146: S-911. DOI: 10.1016/S0016-5085(14)63315-1 |
0.648 |
|
| 2013 |
Patel NS, Peterson MR, Lin GY, Feldstein A, Schnabl B, Bettencourt R, Seki E, Sirlin CB, Loomba R. Insulin Resistance Increases MRI-Estimated Pancreatic Fat in Nonalcoholic Fatty Liver Disease and Normal Controls. Gastroenterology Research and Practice. 2013: 498296. PMID 24348536 DOI: 10.1155/2013/498296 |
0.384 |
|
| 2013 |
Schnabl B. Linking intestinal homeostasis and liver disease. Current Opinion in Gastroenterology. 29: 264-70. PMID 23493073 DOI: 10.1097/Mog.0B013E32835Ff948 |
0.53 |
|
| 2013 |
Hartmann P, Chen P, Wang HJ, Wang L, McCole DF, Brandl K, Stärkel P, Belzer C, Hellerbrand C, Tsukamoto H, Ho SB, Schnabl B. Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in mice. Hepatology (Baltimore, Md.). 58: 108-19. PMID 23408358 DOI: 10.1002/Hep.26321 |
0.546 |
|
| 2013 |
Schnabl B, Brenner DA. Fibroblast growth factor inducible 14 as potential target in patients with alcoholic hepatitis. Gut. 62: 335-6. PMID 22717452 DOI: 10.1136/Gutjnl-2012-302644 |
0.617 |
|
| 2012 |
Brenner DA, Kisseleva T, Scholten D, Paik YH, Iwaisako K, Inokuchi S, Schnabl B, Seki E, De Minicis S, Oesterreicher C, Taura K. Origin of myofibroblasts in liver fibrosis. Fibrogenesis & Tissue Repair. 5: S17. PMID 23259769 DOI: 10.1186/1755-1536-5-S1-S17 |
0.663 |
|
| 2012 |
Hartmann P, Chen WC, Schnabl B. The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease. Frontiers in Physiology. 3: 402. PMID 23087650 DOI: 10.3389/Fphys.2012.00402 |
0.577 |
|
| 2012 |
Hartmann P, Haimerl M, Mazagova M, Brenner DA, Schnabl B. Toll-like receptor 2-mediated intestinal injury and enteric tumor necrosis factor receptor I contribute to liver fibrosis in mice. Gastroenterology. 143: 1330-40.e1. PMID 22841787 DOI: 10.1053/J.Gastro.2012.07.099 |
0.64 |
|
| 2012 |
Brandl K, Tomisato W, Li X, Neppl C, Pirie E, Falk W, Xia Y, Moresco EM, Baccala R, Theofilopoulos AN, Schnabl B, Beutler B. Yip1 domain family, member 6 (Yipf6) mutation induces spontaneous intestinal inflammation in mice. Proceedings of the National Academy of Sciences of the United States of America. 109: 12650-5. PMID 22802641 DOI: 10.1073/Pnas.1210366109 |
0.303 |
|
| 2012 |
Yan AW, Schnabl B. Bacterial translocation and changes in the intestinal microbiome associated with alcoholic liver disease. World Journal of Hepatology. 4: 110-8. PMID 22567183 DOI: 10.4254/Wjh.V4.I4.110 |
0.604 |
|
| 2012 |
Iwaisako K, Haimerl M, Paik YH, Taura K, Kodama Y, Sirlin C, Yu E, Yu RT, Downes M, Evans RM, Brenner DA, Schnabl B. Protection from liver fibrosis by a peroxisome proliferator-activated receptor δ agonist. Proceedings of the National Academy of Sciences of the United States of America. 109: E1369-76. PMID 22538808 DOI: 10.1073/Pnas.1202464109 |
0.629 |
|
| 2012 |
Fouts DE, Torralba M, Nelson KE, Brenner DA, Schnabl B. Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease. Journal of Hepatology. 56: 1283-92. PMID 22326468 DOI: 10.1016/J.Jhep.2012.01.019 |
0.646 |
|
| 2012 |
Seki E, Schnabl B. Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut. The Journal of Physiology. 590: 447-58. PMID 22124143 DOI: 10.1113/Jphysiol.2011.219691 |
0.611 |
|
| 2012 |
Hartmann P, Brandl K, Hellerbrand C, Tsukamoto H, Ho SB, Beutler B, Schnabl B. 928 Deficiency of Intestinal Mucin-2 Protects From Alcoholic Liver Disease in Mice Gastroenterology. 142: S-935. DOI: 10.1016/S0016-5085(12)63626-9 |
0.508 |
|
| 2011 |
Schnabl B, Czech B, Valletta D, Weiss TS, Kirovski G, Hellerbrand C. Increased expression of zinc finger protein 267 in non-alcoholic fatty liver disease. International Journal of Clinical and Experimental Pathology. 4: 661-6. PMID 22076166 |
0.474 |
|
| 2011 |
Schnabl B, Valletta D, Kirovski G, Hellerbrand C. Zinc finger protein 267 is up-regulated in hepatocellular carcinoma and promotes tumor cell proliferation and migration. Experimental and Molecular Pathology. 91: 695-701. PMID 21840307 DOI: 10.1016/J.Yexmp.2011.07.006 |
0.348 |
|
| 2011 |
Brenner DA, Seki E, Taura K, Kisseleva T, Deminicis S, Iwaisako K, Inokuchi S, Schnabl B, Oesterreicher CH, Paik YH, Miura K, Kodama Y. Non-alcoholic steatohepatitis-induced fibrosis: Toll-like receptors, reactive oxygen species and Jun N-terminal kinase. Hepatology Research : the Official Journal of the Japan Society of Hepatology. 41: 683-6. PMID 21711427 DOI: 10.1111/J.1872-034X.2011.00814.X |
0.557 |
|
| 2011 |
Siggs OM, Schnabl B, Webb B, Beutler B. X-linked cholestasis in mouse due to mutations of the P4-ATPase ATP11C Proceedings of the National Academy of Sciences of the United States of America. 108: 7890-7895. PMID 21518881 DOI: 10.1073/Pnas.1104631108 |
0.39 |
|
| 2011 |
Paik YH, Iwaisako K, Seki E, Inokuchi S, Schnabl B, Österreicher CH, Kisseleva T, Brenner DA. The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2/gp91phox mediate hepatic fibrosis in mice Hepatology. 53: 1730-1741. PMID 21384410 DOI: 10.1002/Hep.24281 |
0.623 |
|
| 2011 |
Tacke F, Zimmermann HW, Trautwein C, Schnabl B. CXCL5 plasma levels decrease in patients with chronic liver disease. Journal of Gastroenterology and Hepatology. 26: 523-9. PMID 21332547 DOI: 10.1111/J.1440-1746.2010.06436.X |
0.43 |
|
| 2011 |
Yan AW, Fouts DE, Brandl J, Stärkel P, Torralba M, Schott E, Tsukamoto H, Nelson KE, Brenner DA, Schnabl B. Enteric dysbiosis associated with a mouse model of alcoholic liver disease. Hepatology (Baltimore, Md.). 53: 96-105. PMID 21254165 DOI: 10.1002/Hep.24018 |
0.622 |
|
| 2011 |
Brenner DA, Seki E, Taura K, Kisseleva T, Deminicis S, Iwaisako K, Inokuchi S, Schnabl B, Oesterreicher CH, Paik YH, Miura K, Kodama Y. Non-alcoholic steatohepatitis-induced fibrosis: Toll-like receptors, reactive oxygen species and Jun N-terminal kinase Hepatology Research. 41: 683-686. DOI: 10.1111/j.1872-034X.2011.00814.x |
0.498 |
|
| 2010 |
Miura K, Kodama Y, Inokuchi S, Schnabl B, Aoyama T, Ohnishi H, Olefsky JM, Brenner DA, Seki E. Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice. Gastroenterology. 139: 323-34.e7. PMID 20347818 DOI: 10.1053/J.Gastro.2010.03.052 |
0.48 |
|
| 2010 |
Yan AW, Brandl J, Torralba M, Fouts DE, Schott E, Tsukamoto H, Nelson KE, Brenner DA, Schnabl B. 3 Downregulation of Anti-Microbial Proteins Regenerating Islet-Derived 3 Beta (Reg3b) and Gamma (Reg3g) Contributes to Enteric Dysbiosis in Alcoholic Liver Disease Gastroenterology. 138: S-773. DOI: 10.1016/S0016-5085(10)63564-0 |
0.603 |
|
| 2009 |
Kodama Y, Kisseleva T, Iwaisako K, Miura K, Taura K, De Minicis S, Osterreicher CH, Schnabl B, Seki E, Brenner DA. c-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice. Gastroenterology. 137: 1467-1477.e5. PMID 19549522 DOI: 10.1053/J.Gastro.2009.06.045 |
0.616 |
|
| 2009 |
Kodama Y, Taura K, Miura K, Schnabl B, Osawa Y, Brenner DA. Antiapoptotic Effect of c-Jun N-terminal Kinase-1 through Mcl-1 Stabilization in TNF-Induced Hepatocyte Apoptosis Gastroenterology. 136: 1423-1434. PMID 19249395 DOI: 10.1053/J.Gastro.2008.12.064 |
0.539 |
|
| 2009 |
Brandl K, Rutschmann S, Li X, Du X, Xiao N, Schnabl B, Brenner DA, Beutler B. Enhanced sensitivity to DSS colitis caused by a hypomorphic Mbtps1 mutation disrupting the ATF6-driven unfolded protein response Proceedings of the National Academy of Sciences of the United States of America. 106: 3300-3305. PMID 19202076 DOI: 10.1073/Pnas.0813036106 |
0.444 |
|
| 2009 |
Schnabl B. Peroxisome proliferator‐activated receptor‐δ as emerging target in liver disease Drug Development Research. 71: 106-111. DOI: 10.1002/Ddr.20358 |
0.583 |
|
| 2008 |
De Minicis S, Seki E, Oesterreicher C, Schnabl B, Schwabe RF, Brenner DA. Reduced nicotinamide adenine dinucleotide phosphate oxidase mediates fibrotic and inflammatory effects of leptin on hepatic stellate cells. Hepatology (Baltimore, Md.). 48: 2016-26. PMID 19025999 DOI: 10.1002/Hep.22560 |
0.506 |
|
| 2008 |
Gäbele E, Mühlbauer M, Dorn C, Weiss TS, Froh M, Schnabl B, Wiest R, Schölmerich J, Obermeier F, Hellerbrand C. Role of TLR9 in hepatic stellate cells and experimental liver fibrosis. Biochemical and Biophysical Research Communications. 376: 271-6. PMID 18760996 DOI: 10.1016/J.Bbrc.2008.08.096 |
0.462 |
|
| 2008 |
Schnabl B, Brandl K, Fink M, Gross P, Taura K, Gäbele E, Hellerbrand C, Falk W. A TLR4/MD2 fusion protein inhibits LPS-induced pro-inflammatory signaling in hepatic stellate cells. Biochemical and Biophysical Research Communications. 375: 210-4. PMID 18694726 DOI: 10.1016/J.Bbrc.2008.07.150 |
0.398 |
|
| 2008 |
Miura K, Taura K, Kodama Y, Schnabl B, Brenner DA. Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity. Hepatology (Baltimore, Md.). 48: 1420-9. PMID 18671304 DOI: 10.1002/Hep.22486 |
0.439 |
|
| 2008 |
Schnabl B, Scholten D, Brenner DA. What is the potential role of antifibrotic agents for the treatment of liver disease? Nature Clinical Practice. Gastroenterology & Hepatology. 5: 496-7. PMID 18628735 DOI: 10.1038/Ncpgasthep1200 |
0.642 |
|
| 2007 |
Tacke F, Trautwein C, Yagmur E, Hellerbrand C, Wiest R, Brenner DA, Schnabl B. Up-regulated eotaxin plasma levels in chronic liver disease patients indicate hepatic inflammation, advanced fibrosis and adverse clinical course. Journal of Gastroenterology and Hepatology. 22: 1256-64. PMID 17688666 DOI: 10.1111/J.1440-1746.2006.04621.X |
0.646 |
|
| 2007 |
Brandl K, Plitas G, Schnabl B, DeMatteo RP, Pamer EG. MyD88-mediated signals induce the bactericidal lectin RegIII gamma and protect mice against intestinal Listeria monocytogenes infection. The Journal of Experimental Medicine. 204: 1891-900. PMID 17635956 DOI: 10.1084/Jem.20070563 |
0.316 |
|
| 2007 |
Tacke F, Gäbele E, Bataille F, Schwabe RF, Hellerbrand C, Klebl F, Straub RH, Luedde T, Manns MP, Trautwein C, Brenner DA, Schölmerich J, Schnabl B. Bone morphogenetic protein 7 is elevated in patients with chronic liver disease and exerts fibrogenic effects on human hepatic stellate cells. Digestive Diseases and Sciences. 52: 3404-15. PMID 17415633 DOI: 10.1007/S10620-007-9758-8 |
0.648 |
|
| 2005 |
Meiler C, Muhlbauer M, Johann M, Hartmann A, Schnabl B, Wodarz N, Schmitz G, Scholmerich J, Hellerbrand C. Different effects of a CD14 gene polymorphism on disease outcome in patients with alcoholic liver disease and chronic hepatitis C infection. World Journal of Gastroenterology. 11: 6031-7. PMID 16273620 DOI: 10.3748/Wjg.V11.I38.6031 |
0.518 |
|
| 2005 |
Schnabl B, Choi YH, Hagedorn CH, Bataller R. DNA microarrays and data mining to study hepatic fibrosis. Methods in Molecular Medicine. 117: 359-69. PMID 16118462 DOI: 10.1385/1-59259-940-0:359 |
0.483 |
|
| 2005 |
Schnabl B, Hu K, Mühlbauer M, Hellerbrand C, Stefanovic B, Brenner DA, Schölmerich J. Zinc finger protein 267 is up-regulated during the activation process of human hepatic stellate cells and functions as a negative transcriptional regulator of MMP-10 Biochemical and Biophysical Research Communications. 335: 87-96. PMID 16054593 DOI: 10.1016/J.Bbrc.2005.07.043 |
0.526 |
|
| 2005 |
Hu K, Fink M, Froh M, Gäbele E, Hellerbrand C, Mühlbauer M, Wiest R, Schölmerich J, Schnabl B. Characterization of the human zinc finger protein 267 promoter: Essential role of nuclear factor Y Biochimica Et Biophysica Acta - Gene Structure and Expression. 1729: 14-23. PMID 15814297 DOI: 10.1016/J.Bbaexp.2005.03.001 |
0.357 |
|
| 2004 |
Mühlbauer M, Weiss TS, Thasler WE, Gelbmann CM, Schnabl B, Schölmerich J, Hellerbrand C. LPS-mediated NFkappaB activation varies between activated human hepatic stellate cells from different donors. Biochemical and Biophysical Research Communications. 325: 191-7. PMID 15522218 DOI: 10.1016/J.Bbrc.2004.10.020 |
0.506 |
|
| 2004 |
Stefanovic B, Stefanovic L, Schnabl B, Bataller R, Brenner DA. TRAM2 protein interacts with endoplasmic reticulum Ca2+ pump Serca2b and is necessary for collagen type I synthesis. Molecular and Cellular Biology. 24: 1758-68. PMID 14749390 DOI: 10.1128/Mcb.24.4.1758-1768.2004 |
0.466 |
|
| 2004 |
STEFANOVIC B, LINDQUIST J, RIPPE R, SCHNABL B, SCHWABE R, BATALLER R, BRENNER D. Prevention and treatment of hepatic fibrosis at the cellular level Journal of Gastroenterology and Hepatology. 19: S246-S252. DOI: 10.1111/J.1440-1746.2004.03681.X |
0.4 |
|
| 2003 |
Kweon YO, Paik YH, Schnabl B, Qian T, Lemasters JJ, Brenner DA. Gliotoxin-mediated apoptosis of activated human hepatic stellate cells. Journal of Hepatology. 39: 38-46. PMID 12821042 DOI: 10.1016/S0168-8278(03)00178-8 |
0.599 |
|
| 2003 |
Schnabl B, Purbeck CA, Choi YH, Hagedorn CH, Brenner D. Replicative senescence of activated human hepatic stellate cells is accompanied by a pronounced inflammatory but less fibrogenic phenotype. Hepatology (Baltimore, Md.). 37: 653-64. PMID 12601363 DOI: 10.1053/Jhep.2003.50097 |
0.506 |
|
| 2002 |
Schnabl B, Choi YH, Olsen JC, Hagedorn CH, Brenner DA. Immortal activated human hepatic stellate cells generated by ectopic telomerase expression. Laboratory Investigation; a Journal of Technical Methods and Pathology. 82: 323-33. PMID 11896211 DOI: 10.1038/Labinvest.3780426 |
0.498 |
|
| 2002 |
Stefanovic B, Schnabl B, Brenner DA. Inhibition of collagen alpha 1(I) expression by the 5' stem-loop as a molecular decoy. The Journal of Biological Chemistry. 277: 18229-37. PMID 11889120 DOI: 10.1074/Jbc.M108065200 |
0.435 |
|
| 2001 |
Schnabl B, Bradham CA, Bennett BL, Manning AM, Stefanovic B, Brenner DA. TAK1/JNK and p38 have opposite effects on rat hepatic stellate cells. Hepatology (Baltimore, Md.). 34: 953-63. PMID 11679966 DOI: 10.1053/Jhep.2001.28790 |
0.498 |
|
| 2001 |
Schnabl B, Kweon YO, Frederick JP, Wang XF, Rippe RA, Brenner DA. The role of Smad3 in mediating mouse hepatic stellate cell activation. Hepatology (Baltimore, Md.). 34: 89-100. PMID 11431738 DOI: 10.1053/Jhep.2001.25349 |
0.522 |
|
| 2001 |
Schwabe RF, Schnabl B, Kweon YO, Brenner DA. CD40 activates NF-κB and c-Jun N-terminal kinase and enhances chemokine secretion on activated human hepatic stellate cells Journal of Immunology. 166: 6812-6819. PMID 11359840 DOI: 10.4049/Jimmunol.166.11.6812 |
0.514 |
|
| 2000 |
Schwabe RF, Schnabl B, Brenner DA. CD40 activates NFKB and JNK and enhances IL-8 secretion on human hepatic myofibroblasts Gastroenterology. 118. DOI: 10.1016/S0016-5085(00)86204-6 |
0.477 |
|
| 2000 |
Schnabl B, Lim S, Kweon Y, Wang X, Rippe RA, Brenner DA. The in vivo role of Sma3 in mediating CCl4 induced liver fibrosis Gastroenterology. 118. DOI: 10.1016/S0016-5085(00)86095-3 |
0.634 |
|
| Show low-probability matches. |